Review series: Rehabilitation in non COPD: Mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease

Abstract

The standard of care in the treatment of chronic lung disease includes pulmonary rehabilitation (PR). While evidence of the effectiveness of PR in chronic obstructive lung disease (COPD) is robust, that for pulmonary fibrosis and other non-fibrotic restrictive lung diseases is less extensive. However, PR has been shown to improve functional exercise capacity and health-related quality of life in non-COPD patients, primarily those with interstitial lung diseases. This review examines mechanisms of exercise limitation in non-COPD patients and discusses how they might affect both the application of and outcome measures of PR. We also review the assessment of exercise performance, dyspnea, and quality of life as well as special protocols, safety considerations, and special techniques in PR as applied to patients with pulmonary fibrosis or restrictive lung disease. At present, there are no evidence-based guidelines for PR in non-COPD patients whereas PR is firmly recommended in COPD management. More research is needed to strengthen the evidence for the use of PR in non-COPD patients. Meanwhile, the available data, summarized in this review, support the inclusion of PR in the management of all patients with chronic lung disease including pulmonary fibrosis and restrictive lung disease.

Keywords

Rehabilitation interstitial lung disease pulmonary fibrosis

References

Cooper CB Exercise in chronic pulmonary disease: limitations and rehabilitation . Med Sci Sports Exerc 2001; 33: S643-S646.

American Thoractic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoractic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000 ; 161: 646-664.

Bourbeau J. , Julien M. , Maltais F. , et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003; 163: 585-591.

Ries AL , Bauldoff GS , Carlin BW , et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007; 131: 4S-42S.

Anderson SD , Bye PT Exercise testing in the evaluation of diffuse interstitial lung disease . Aust NZJ Med 1984; 14: 762-768.

Hansen JE , Wasserman K. Pathophysiology of activity limitation in patients with interstitial lung disease. Chest 1996; 109: 1566-1576.

Markovitz GH , Cooper CB Exercise and interstitial lung disease. Curr Opin Pulm Med 1998; 4: 272-280.

Murphy DM , Hall DR , Petersen MR , Lapp NL The effect of diffuse pulmonary fibrosis on lung mechanics. Bull Eur Physiopathol Respir 1981; 17: 27-41.

Marciniuk DD , Sridhar G. , Clemens RE , Zintel TA , Gallagher CG Lung volumes and expiratory flow limitation during exercise in interstitial lung disease . J Appl Physiol 1994; 77: 963-973.

10.

Bye PT , Anderson SD , Woolcock AJ , Young IH , Alison JA Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am Rev Respir Dis 1982; 126: 1005-1012.

11.

Cotes JE , Zejda J. , King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am Rev Respir Dis 1988; 137: 1089-1093.

12.

Burdon JG , Killian KJ , Jones NL Pattern of breathing during exercise in patients with interstitial lung disease . Thorax 1983; 38: 778-784.

13.

Harris-Eze AO , Sridhar G. , Clemens RE , Zintel TA , Gallagher CG , Marciniuk DD Role of hypoxemia and pulmonary mechanics in exercise limitation in interstitial lung disease . Am J Respir Crit Care Med 1996; 154: 994-1001.

14.

Agusti AG , Roca J. , Gea J. , Wagner PD , Xaubet A. , Rodriguez-Roisin R. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis . Am Rev Respir Dis 1991; 143: 219-225.

15.

Agusti A. , Arnau JM , Laporte JR Clinical trials versus clinical practice in the secondary prevention of myocardial infarction. Eur J Clin Pharmacol 1994; 46: 95-99.

16.

Widimsky J. , Riedel M. , Stanek V. Central haemodynamics during exercise in patients with restrictive pulmonary disease. Bull Eur Physiopathol Respir 1977; 13: 369-379.

17.

Van Meerhaeghe A. , Scano G. , Sergysels R. , Bran M. , De Coster A. Respiratory drive and ventilatory pattern during exercise in interstitial lung disease . Bull Eur Physiopathol Respir 1981; 17: 15-26.

18.

O’Donnell DE , Webb KA Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-1357.

19.

Nield M. , Arora A. , Dracup K. , Hoo GW , Cooper CB Comparison of breathing patterns during exercise in patients with obstructive and restrictive ventilatory abnormalities. J Rehabil Res Dev 2003; 40: 407-414.

20.

Nici L. , Donner C. , Wouters E. , et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.

21.

Kim HC , Mofarrahi M. , Hussain SN Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008 ; 3: 637-658.

22.

Nishiyama O. , Kondoh Y. , Kimura T. , et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008; 13: 394-399.

23.

Wirnsberger RM , Drent M. , Hekelaar N. , et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997; 10: 1450-1455.

24.

Baydur A. , Alsalek M. , Louie SG , Sharma OP Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis . Chest 2001; 120: 102-108.

25.

Spruit MA , Thomeer MJ , Gosselink R. , et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60: 32-38.

26.

Tirdel GB , Girgis R. , Fishman RS , Theodore J. Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients. J Heart Lung Transplant 1998; 17: 1231-1237.

27.

Wang XN , Williams TJ , McKenna MJ , et al. Skeletal muscle oxidative capacity, fiber type, and metabolites after lung transplantation. Am J Respir Crit Care Med 1999; 160: 57-63.

28.

Pantoja JG , Andrade FH , Stoki DS , Frost AE , Eschenbacher WL , Reid MB Respiratory and limb muscle function in lung allograft recipients . Am J Respir Crit Care Med 1999; 160: 1205-1211.

29.

Reinsma GD , ten Hacken NH , Grevink RG , van der Bij W. , Koeter GH , van Weert E. Limiting factors of exercise performance 1 year after lung transplantation . J Heart Lung Transplant 2006; 25: 1310-1316.

30.

Maury G. , Langer D. , Verleden G. , et al. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant 2008; 8: 1275-1281.

31.

Lacasse Y. , Brosseau L. , Milne S. , et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease . Cochrane Database Syst Rev 2002: CD003793.

32.

Foster S. , Thomas HM, 3rd. Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141: 601-604.

33.

Bickford LS , Hodgkin JE , McInturff SL National pulmonary rehabilitation survey. Update. J Cardiopulm Rehabil 1995; 15: 406-411.

34.

Novitch RS , Thomas HMI. Pulmonary rehabilitation in chronic pulmonary interstitial disease . In: Fishman A (ed.) Pulmonary rehabilitation . New York, NY: Marcel Dekker, 1996, p.683-700.

35.

Crouch R. , MacIntyre NR Pulmonary rehabilitation of the patient with nonobstructive lung disease . Respir Care Clin N Am 1998; 4: 59-70.

36.

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.

37.

Naji NA , Connor MC , Donnelly SC , McDonnell TJ Effectiveness of pulmonary rehabilitation in restrictive lung disease . J Cardiopulm Rehabil 2006; 26: 237-243.

38.

Ferreira A. , Garvey C. , Connors GL , et al. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest 2009; 135: 442-447.

39.

Holland AE , Hill CJ , Conron M. , Munro P. , McDonald CF Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008; 63: 549-554.

40.

Redelmeier DA , Bayoumi AM , Goldstein RS , Guyatt GH Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.

41.

Knox AJ , Morrison JF , Muers MF Reproducibility of walking test results in chronic obstructive airways disease . Thorax 1988; 43: 388-392.

42.

Enright PL , Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384-1387.

43.

Cooper CB Exercise in chronic pulmonary disease: aerobic exercise prescription . Med Sci Sports Exerc 2001; 33: S671-S679.

44.

Lacasse Y. , Wong E. , Guyatt GH , King D. , Cook DJ , Goldstein RS Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-1119.

45.

Puhan MA , Mador MJ , Held U. , Goldstein R. , Guyatt GH , Schunemann HJ Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008; 32: 637-643.

46.

Eaton T. , Young P. , Milne D. , Wells AU Six-Minute Walk, Maximal Exercise Tests. Reproducibility in Fibrotic Interstitial Pneumonia. Am J Respir Crit Care Med 2005; 171: 1150-1157.

47.

Nishiyama O. , Taniguchi H. , Kondoh Y. , et al. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: Comparison with COPD. Respir Med 2007; 101: 833-838.

48.

Reardon JZ , Lareau SC , ZuWallack R. Functional status and quality of life in chronic obstructive pulmonary disease . Am J Med 2006; 119: 32-37.

49.

Swigris JJ , Kuschner WG , Kelsey JL , Gould MK Idiopathic pulmonary fibrosis: challenges and opportunities for the clinician and investigator. Chest 2005; 127: 275-283.

50.

Swigris JJ , Kuschner WG , Jacobs SS , Wilson SR , Gould MK Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005 ; 60: 588-594.

51.

De Vries J. , Kessels BL , Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur Respir J 2001; 17: 954-961.

52.

Martinez TY , Pereira CA , dos Santos ML , Ciconelli RM , Guimaraes SM , Martinez JA Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 2000; 117: 1627-1632.

53.

Tzanakis N. , Samiou M. , Lambiri I. , Antoniou K. , Siafakas N. , Bouros D. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med 2005; 16: 105-112.

54.

Chang JA , Curtis JR , Patrick DL , Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116: 1175-1182.

55.

Hajiro T. , Nishimura K. , Tsukino M. , Ikeda A. , Koyama H. , Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 785-790.

56.

Swigris JJ , Stewart AL , Gould MK , Wilson SR Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005; 3: 61.

57.

Jastrzebski D. , Gumola A. , Gawlik R. , Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol 2006 ; 57: 139-148.

58.

Ries AL

ACCP/AACVPR evidence-based guidelines for pulmonary rehabilitation. Round 3: another step forward

J Cardiopulm Rehabil Prev 2007; 27: 233-236.

59.

Griffiths TL , Burr ML , Campbell IA , et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000; 355: 362-368.

60.

Spruit MA , Wouters EF New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Sports Med 2007; 37: 501-518.

61.

Casaburi R. , Kukafka D. , Cooper CB , Witek TJ, Jr , Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD . Chest 2005; 127: 809-817.

62.

Somfay A. , Porszasz J. , Lee SM , Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 2001; 18: 77-84.

63.

Emtner M. , Porszasz J. , Burns M. , Somfay A. , Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168: 1034-1042.

64.

Van’t Hul A. , Harlaar J. , Gosselink R. , Hollander P. , Postmus P. , Kwakkel G. Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease. Muscle Nerve 2004; 29: 267-274.

65.

Van’t Hul A. , Gosselink R. , Hollander P. , Postmus P. , Kwakkel G. Acute effects of inspiratory pressure support during exercise in patients with COPD. Eur Respir J 2004; 23: 34-40.

66.

Schonhofer B. , Zimmermann C. , Abramek P. , Suchi S. , Kohler D. , Polkey MI Non-invasive mechanical ventilation improves walking distance but not quadriceps strength in chronic respiratory failure . Respir Med 2003; 97: 818-824.

67.

Lotters F. , van Tol B. , Kwakkel G. , Gosselink R. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J 2002; 20: 570-576.

68.

Mador MJ , Deniz O. , Aggarwal A. , Shaffer M. , Kufel TJ , Spengler CM Effect of respiratory muscle endurance training in patients with COPD undergoing pulmonary rehabilitation. Chest 2005; 128: 1216-1224.

69.

Vogiatzis I. , Terzis G. , Nanas S. , et al. Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest 2005; 128: 3838-3845.

70.

Sabapathy S. , Kingsley RA , Schneider DA , Adams L. , Morris NR Continuous and intermittent exercise responses in individuals with chronic obstructive pulmonary disease. Thorax 2004; 59: 1026-1031.

71.

Mador MJ , Bozkanat E. , Aggarwal A. , Shaffer M. , Kufel TJ Endurance and strength training in patients with COPD. Chest 2004; 125: 2036-2045.

72.

Ortega F. , Toral J. , Cejudo P. , et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 669-674.

73.

Zanotti E. , Felicetti G. , Maini M. , Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest 2003; 124: 292-296.

74.

Neder JA , Sword D. , Ward SA , Mackay E. , Cochrane LM , Clark CJ Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333-337.

75.

Fuld JP , Kilduff LP , Neder JA , et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 2005; 60: 531-537.

76.

Casaburi R. , Bhasin S. , Cosentino L. , et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 870-878.

77.

Creutzberg EC , Wouters EF , Mostert R. , Pluymers RJ , Schols AM A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial . Chest 2003; 124: 1733-1742.

78.

Broekhuizen R. , Wouters EF , Creutzberg EC , Weling-Scheepers CA , Schols AM Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease . Thorax 2005; 60: 376-382.

79.

Shaw RJ , Djukanovic R. , Tashkin DP , Millar AB , du Bois RM , Orr PA The role of small airways in lung disease. Respir Med 2002; 96: 67-80.

80.

Barakat S. , Michele G. , Nesme P. , Nicole V. , Guy A. Effect of a noninvasive ventilatory support during exercise of a program in pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2007; 2: 585-591.

81.

Hill K. , Jenkins SC , Phillipe DL , Cecins N. , Shepherd KL , Green DJ , Hillman DR , Eastwood PR High-intensity inspiratory muscle training in COPD. Eur Respir J 2006; 27: 1119-1128.

82.

Kobayashi N. , Miyazawa N. , Ogura T. , et al. Eighty cases of chronic respiratory failure treated with home noninvasive positive pressure ventilation. Nihon Kokyuki Gakkai Zasshi 2005; 43: 3-9 (in Japanese).

83.

Vogiatzis I. , Nanas S. , Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J 2002; 20: 12-19.

84.

Probst VS , Troosters T. , Pitta F. , Decramer M. , Gosselink R. Cardiopulmonary stress during exercise training in patients with COPD . Eur Respir J 2006; 27: 1110-1118.

85.

O’Shea SD , Taylor NF , Paratz J. Peripheral muscle strength training in COPD: a systematic review. Chest 2004; 126: 903-914.

86.

Bernard S. , Whittom F. , Leblanc P. , et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 896-901.